EPC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Edgewell Personal Care Co (EPC) is not a strong buy for a beginner, long-term investor at this time. While the stock has shown some positive momentum and analyst upgrades, the financial performance and technical indicators suggest caution. The company's negative net income and overbought RSI indicate potential risks. Additionally, there are no significant trading signals or recent catalysts to justify an immediate buy.
The MACD is positive at 0.171, indicating bullish momentum, but it is contracting. The RSI is at 81.836, signaling an overbought condition. Moving averages are converging, suggesting indecision in the market. The stock is trading near its R1 resistance level of 22.241, which could act as a barrier for further upward movement.
Analysts have raised price targets recently, with Wells Fargo highlighting an improved portfolio post-divestiture. The company has shown revenue growth of 1.85% YoY in Q1 2026.
The company's net income remains negative at -$65.7M despite a significant YoY improvement. Gross margin has dropped by 5.08% YoY. The RSI indicates overbought conditions, and there are no significant hedge fund or insider trading trends.
In Q1 2026, revenue increased by 1.85% YoY to $422.8M. Net income improved significantly but remains negative at -$65.7M. EPS increased by 3425% YoY but is still negative at -1.41. Gross margin declined by 5.08% YoY to 39.45%.
Analysts have shown mixed sentiment. Wells Fargo raised the price target to $24, maintaining an Overweight rating, citing an improved portfolio. Barclays raised the price target to $21 with an Equal Weight rating, noting that fiscal Q1 results were in line with expectations. However, there is still a need for visibility into the company's performance in the second half of 2026.
